New Mexico Medical Psilocybin Act: What It Means and What Comes Next
New Mexico became the third US state to create a regulated psilocybin access framework when Governor Michelle Lujan Grisham signed the Medical Psilocybin Act in April 2025. Here is what the law does, what it does not do, and the expected timeline to first patient enrollment.
What the Law Does
The New Mexico Medical Psilocybin Act creates a state-regulated medical framework for supervised psilocybin administration under Department of Health rules. Key provisions:
Qualified patients: The program is medical, not open adult-use access. New Mexico's public program materials list treatment-resistant depression, PTSD, substance use disorders, and end-of-life care among the qualifying areas being built into the program.
Supervised administration: Psilocybin is not a take-home retail product. Services depend on final rules for approved settings, medical standards, training, and supervision.
Department of Health buildout: DOH is responsible for rules, licensing infrastructure, safety standards, and implementation. The official FAQ says the department is targeting first patient enrollment by the end of December 2026.
No purchase or possession outside approved settings: Unlike Colorado, New Mexico's law does not include personal cultivation or home-use provisions.
Implementation deadline: The statute gives the state until December 31, 2027 to implement the program, even though DOH has publicly described a faster first-patient target.
What the Law Does NOT Do
- Decriminalize general personal possession
- Authorize home cultivation or personal adult use
- Create instant service centers, retail sales, or mail-order access
- Make psilocybin federally approved medicine or general public therapy
Expected Timeline
2025: Senate Bill 219 passed in the 2025 legislative session and was signed by Governor Michelle Lujan Grisham in April 2025.
2026: Regulatory rulemaking, advisory board work, program staffing, and first-patient launch planning. DOH says the goal is first patient enrollment by the end of December 2026.
2027: Statutory implementation deadline is December 31, 2027. Availability still depends on final rules, application review, provider readiness, and approved settings.
How It Compares to Oregon and Colorado
| | Oregon | Colorado | New Mexico | |--|--|--|--| | Year operational | 2023 | 2025 | Target first patients by Dec. 2026; implementation deadline Dec. 31, 2027 | | Home cultivation | No | Yes for personal use under state law | No | | Personal possession | No adult-use possession outside service model | Yes for adults under state law | No general personal-use protection | | Access model | Adult supervised services | Personal-use protections plus regulated healing centers | Medical program for qualifying patients | | Substances covered | Psilocybin only | Natural medicine framework | Psilocybin only |
New Mexico's framework is more medical and condition-linked than Oregon's adult service-center model, and much narrower than Colorado's personal-use protections.
What This Means for Residents
New Mexico residents currently seeking legal regulated psilocybin access should not assume in-state services are open yet. The official path is still being built. Until enrollment and licensed settings are active, Oregon and Colorado remain the operating state-regulated options in the United States.
Watch the New Mexico Department of Health website for regulatory updates, advisory board materials, enrollment timing, provider rules, and safety standards.